Table 7.
Major fracture | OR | 95% CI | P valuec |
Age | 1.066 | 1.052-1.08 | <0.0001 |
Sex, female | |||
<55 | 1 | ||
>=55 | 5.011 | 2.55-9.844 | <0.0001 |
FRAX-majora | 1.069 | 1.051-1.086 | <0.0001 |
MTHFR rs1801133 | |||
GG | 1 | ||
GA | 0.821 | 0.608-1.108 | 0.198 |
AA | 1.236 | 0.759-2.015 | 0.3943 |
Hip fracture | OR | 95% CI | P valuec |
Age | 1.084 | 1.057-1.111 | <0.0001 |
Sex, female | |||
<55 | 1 | ||
>=55 | 5.568 | 1.353-22.906 | 0.0174 |
FRAX-hipb | 1.09 | 1.059-1.121 | <0.0001 |
MTHFR rs1801133 | |||
GG | 1 | ||
GA | 0.754 | 0.429-1.326 | 0.3274 |
AA | 0.607 | 0.185-1.992 | 0.4104 |
aFRAX-major risk exceeding 20% vs. FRAX-major risk below 20%.
bFRAX-hip risk exceeding 3% vs. FRAX-hip risk below 3%.
cBy logistic regression with adjustment of age, sex, and FRAX.